Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matija Snuderl

Showing results (151-160 of 270) with videos related to

Pageof 27
Sort By:
Science Advances|November 8, 2018
Multiple modes of PRC2 inhibition elicit global chromatin alterations in H3K27M pediatric gliomaJames M Stafford, Chul-Hwan Lee, Philipp Voigt, et al.
Acta Neuropathologica|November 5, 2016
Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathwayJason T Huse, Matija Snuderl, David T W Jones, et al.
The Journal of Investigative Dermatology|November 10, 2021
Deep Learning and Pathomics Analyses Reveal Cell Nuclei as Important Features for Mutation Prediction of BRAF-Mutated MelanomasRandie H Kim, Sofia Nomikou, Nicolas Coudray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2022
Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent TERT RearrangementsTheodore Vougiouklakis, Kelsey Zhu, Varshini Vasudevaraja, et al.
Brain Pathology (Zurich, Switzerland)|March 8, 2020
MiR-1253 exerts tumor-suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7-H3)Ranjana K Kanchan, Naveenkumar Perumal, Pranita Atri, et al.
The Journal of Pathology|March 28, 2025
MicroRNA-371-373 cluster and methylome analysis suggests that a subset of 'somatic-type' malignancies arising in germ cell tumors may originate in yolk sac tumor componentsJoão Lobo, Nuno Tiago Tavares, Diana Fonseca, et al.
Cell Reports|March 21, 2019
Modeling Patient-Derived Glioblastoma with Cerebral OrganoidsAmanda Linkous, Demosthenes Balamatsias, Matija Snuderl, et al.
Acta Neuropathologica Communications|July 16, 2020
Molecular and clinicopathologic features of gliomas harboring NTRK fusionsMatthew Torre, Varshini Vasudevaraja, Jonathan Serrano, et al.
Elife|September 10, 2020
Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapyXin Cui, Chao Ma, Varshini Vasudevaraja, et al.
Acta Neuropathologica Communications|November 3, 2023
Variant allelic frequencies of driver mutations can identify gliomas with potentially false-negative MGMT promoter methylation resultsMatthew McCord, Pouya Jamshidi, Vineeth Thirunavu, et al.
Pageof 27

Showing results (151-160 of 270) with videos related to

Sort By:
Pageof 27
Science Advances|November 8, 2018
Multiple modes of PRC2 inhibition elicit global chromatin alterations in H3K27M pediatric gliomaJames M Stafford, Chul-Hwan Lee, Philipp Voigt, et al.
Acta Neuropathologica|November 5, 2016
Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathwayJason T Huse, Matija Snuderl, David T W Jones, et al.
The Journal of Investigative Dermatology|November 10, 2021
Deep Learning and Pathomics Analyses Reveal Cell Nuclei as Important Features for Mutation Prediction of BRAF-Mutated MelanomasRandie H Kim, Sofia Nomikou, Nicolas Coudray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2022
Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent TERT RearrangementsTheodore Vougiouklakis, Kelsey Zhu, Varshini Vasudevaraja, et al.
Brain Pathology (Zurich, Switzerland)|March 8, 2020
MiR-1253 exerts tumor-suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7-H3)Ranjana K Kanchan, Naveenkumar Perumal, Pranita Atri, et al.
The Journal of Pathology|March 28, 2025
MicroRNA-371-373 cluster and methylome analysis suggests that a subset of 'somatic-type' malignancies arising in germ cell tumors may originate in yolk sac tumor componentsJoão Lobo, Nuno Tiago Tavares, Diana Fonseca, et al.
Cell Reports|March 21, 2019
Modeling Patient-Derived Glioblastoma with Cerebral OrganoidsAmanda Linkous, Demosthenes Balamatsias, Matija Snuderl, et al.
Acta Neuropathologica Communications|July 16, 2020
Molecular and clinicopathologic features of gliomas harboring NTRK fusionsMatthew Torre, Varshini Vasudevaraja, Jonathan Serrano, et al.
Elife|September 10, 2020
Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapyXin Cui, Chao Ma, Varshini Vasudevaraja, et al.
Acta Neuropathologica Communications|November 3, 2023
Variant allelic frequencies of driver mutations can identify gliomas with potentially false-negative MGMT promoter methylation resultsMatthew McCord, Pouya Jamshidi, Vineeth Thirunavu, et al.
Pageof 27